Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nhien Nguyen

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Malaria Journal|August 27, 2021
Clustering of malaria in households in the Greater Mekong Subregion: operational implications for reactive case detectionMavuto Mukaka, Pimnara Peerawaranun, Daniel M Parker, et al.
Bulletin of the World Health Organization|December 11, 2019
Provider and household costs of <i>Plasmodium vivax</i> malaria episodes: a multicountry comparative analysis of primary trial dataAngela Devine, Ayodhia P Pasaribu, Tedlla Teferi, et al.
Plos One|March 26, 2019
Community engagement, social context and coverage of mass anti-malarial administration: Comparative findings from multi-site research in the Greater Mekong sub-RegionChristopher L Pell, Bipin Adhikari, May Myo Thwin, et al.
Malaria Journal|October 2, 2015
The epidemiology of subclinical malaria infections in South-East Asia: findings from cross-sectional surveys in Thailand-Myanmar border areas, Cambodia, and VietnamMallika Imwong, Thuy Nhien Nguyen, Rupam Tripura, et al.
Malaria Journal|September 10, 2021
Development of weight and age-based dosing of daily primaquine for radical cure of vivax malariaWalter Robert Taylor, Richard M Hoglund, Pimnara Peerawaranun, et al.
Plos One|February 6, 2020
Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trialsKoukeo Phommasone, Frank van Leth, Thomas J Peto, et al.
Nature Genetics|January 20, 2015
Genetic architecture of artemisinin-resistant Plasmodium falciparumOlivo Miotto, Roberto Amato, Elizabeth A Ashley, et al.
Plos Medicine|February 16, 2019
The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trialLorenz von Seidlein, Thomas J Peto, Jordi Landier, et al.
Wellcome Open Research|June 2, 2022
An open dataset of <i>Plasmodium vivax</i> genome variation in 1,895 worldwide samples, Ishag Adam, Mohammad Shafiul Alam, et al.
Wellcome Open Research|November 21, 2025
Pf8: an open dataset of <i>Plasmodium falciparum </i>genome variation in 33,325 worldwide samples, Muzamil Mahdi Abdel Hamid, Mohamed Hassan Abdelraheem, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Malaria Journal|August 27, 2021
Clustering of malaria in households in the Greater Mekong Subregion: operational implications for reactive case detectionMavuto Mukaka, Pimnara Peerawaranun, Daniel M Parker, et al.
Bulletin of the World Health Organization|December 11, 2019
Provider and household costs of <i>Plasmodium vivax</i> malaria episodes: a multicountry comparative analysis of primary trial dataAngela Devine, Ayodhia P Pasaribu, Tedlla Teferi, et al.
Plos One|March 26, 2019
Community engagement, social context and coverage of mass anti-malarial administration: Comparative findings from multi-site research in the Greater Mekong sub-RegionChristopher L Pell, Bipin Adhikari, May Myo Thwin, et al.
Malaria Journal|October 2, 2015
The epidemiology of subclinical malaria infections in South-East Asia: findings from cross-sectional surveys in Thailand-Myanmar border areas, Cambodia, and VietnamMallika Imwong, Thuy Nhien Nguyen, Rupam Tripura, et al.
Malaria Journal|September 10, 2021
Development of weight and age-based dosing of daily primaquine for radical cure of vivax malariaWalter Robert Taylor, Richard M Hoglund, Pimnara Peerawaranun, et al.
Plos One|February 6, 2020
Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trialsKoukeo Phommasone, Frank van Leth, Thomas J Peto, et al.
Nature Genetics|January 20, 2015
Genetic architecture of artemisinin-resistant Plasmodium falciparumOlivo Miotto, Roberto Amato, Elizabeth A Ashley, et al.
Plos Medicine|February 16, 2019
The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trialLorenz von Seidlein, Thomas J Peto, Jordi Landier, et al.
Wellcome Open Research|June 2, 2022
An open dataset of <i>Plasmodium vivax</i> genome variation in 1,895 worldwide samples, Ishag Adam, Mohammad Shafiul Alam, et al.
Wellcome Open Research|November 21, 2025
Pf8: an open dataset of <i>Plasmodium falciparum </i>genome variation in 33,325 worldwide samples, Muzamil Mahdi Abdel Hamid, Mohamed Hassan Abdelraheem, et al.
Pageof 4